JP2017517255A5 - - Google Patents

Download PDF

Info

Publication number
JP2017517255A5
JP2017517255A5 JP2016568573A JP2016568573A JP2017517255A5 JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5 JP 2016568573 A JP2016568573 A JP 2016568573A JP 2016568573 A JP2016568573 A JP 2016568573A JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5
Authority
JP
Japan
Prior art keywords
particles
micronized
diameter
jelly
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016568573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/032078 external-priority patent/WO2015179711A1/en
Publication of JP2017517255A publication Critical patent/JP2017517255A/ja
Publication of JP2017517255A5 publication Critical patent/JP2017517255A5/ja
Priority to JP2020096350A priority Critical patent/JP7304316B2/ja
Pending legal-status Critical Current

Links

JP2016568573A 2014-05-21 2015-05-21 微粉化ホウォートンゼリー Pending JP2017517255A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020096350A JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462001600P 2014-05-21 2014-05-21
US62/001,600 2014-05-21
PCT/US2015/032078 WO2015179711A1 (en) 2014-05-21 2015-05-21 Micronized wharton's jelly

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020096350A Division JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Publications (2)

Publication Number Publication Date
JP2017517255A JP2017517255A (ja) 2017-06-29
JP2017517255A5 true JP2017517255A5 (enExample) 2018-06-14

Family

ID=54554801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568573A Pending JP2017517255A (ja) 2014-05-21 2015-05-21 微粉化ホウォートンゼリー
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Country Status (5)

Country Link
US (1) US20150335686A1 (enExample)
EP (1) EP3146039A4 (enExample)
JP (2) JP2017517255A (enExample)
AU (2) AU2015264025A1 (enExample)
WO (1) WO2015179711A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2999420A1 (en) 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
ES2822301T3 (es) 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
JP6640826B2 (ja) 2014-07-08 2020-02-05 ミメディクス グループ インコーポレイテッド 微粒子化ワルトン膠質
US10201573B1 (en) * 2014-10-27 2019-02-12 Brahm Holdings, Llc Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
EP3297645A4 (en) 2015-05-20 2018-12-12 Tissuetech, Inc. Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
WO2017100425A1 (en) * 2015-12-10 2017-06-15 Aesthetics Biomedical, Inc. Topical formulation for skin care
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US10463699B2 (en) 2016-04-04 2019-11-05 Omeza LLC Fish oil topical composition
US11318168B2 (en) * 2016-06-24 2022-05-03 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
FR3070262B1 (fr) 2017-08-23 2020-10-16 Tbf Genie Tissulaire Tbf Composition comprenant de la gelee de wharton, procede de preparation et utilisations
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
WO2019060355A1 (en) * 2017-09-19 2019-03-28 Petrucci Gary M PREPARATION OF AMNIOTIC FABRIC AND METHODS OF USE
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
WO2019079672A1 (en) * 2017-10-19 2019-04-25 Lifecell Corporation ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION
EP4009994A4 (en) * 2019-08-08 2023-06-21 Tissue Regeneration Therapeutics Inc. Perivascular lysates and uses thereof
EP4117626A1 (en) * 2020-03-12 2023-01-18 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
WO2022159789A1 (en) * 2021-01-25 2022-07-28 Biostem Technologies, Inc. Two-part clotting composition and methods of making and using thereof
CA3255906A1 (en) * 2022-04-20 2023-10-26 Biostem Technologies, Inc. Human amniotic composition processed in several parts and its processes of manufacture and use for the treatment of Peyronie's disease
CA3263067A1 (en) * 2022-07-26 2024-02-01 Biostem Technologies, Inc. COMPOSITIONS BASED ON HUMAN UMBILICAL CORD AND INTRA-ARTICULAR THERAPY METHODS
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) * 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US9005646B2 (en) * 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8071135B2 (en) * 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
CN102176881B (zh) * 2008-10-10 2014-12-10 海斯特赛尔有限公司 来自人脐带的脐带胶质的新生物材料
CN102198292B (zh) * 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
EP2552457B1 (en) * 2010-03-30 2015-07-29 Histocell, S.L. Biomaterial from wharton's jelly umbilical cord
WO2012112410A2 (en) * 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
CA2826433C (en) * 2011-02-14 2022-05-31 Brenda S. Morse Micronized placental tissue compositions and methods of making and using the same
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
SI3321355T1 (sl) * 2011-12-30 2021-11-30 Amit Patel Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
WO2014028657A1 (en) * 2012-08-15 2014-02-20 Mimedx Group, Inc Reinforced placental tissue grafts and methods of making and using the same
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US20150086634A1 (en) * 2013-09-10 2015-03-26 Mimedx Group, Inc. Cosmetic uses of molded placental compositions

Similar Documents

Publication Publication Date Title
JP2017517255A5 (enExample)
JP5298307B2 (ja) 半合成の血小板ゲル及びその調製方法
AU2015287920A8 (en) Micronized Wharton's Jelly
JP2017525671A5 (enExample)
JP2013530955A5 (enExample)
JP2016216487A5 (enExample)
ME02868B (me) POSTUPCI, CEV, l UREĐAJ ZA DOBIJANJE KOMPOZICIJE ZA ZARASTANJE RANA
CR9704A (es) Composicion farmaceutica de liberacion modificada, proceso de preparacion y metodo para emplear la misma.
JP2013527217A5 (enExample)
WO2013096792A1 (en) Method for repairing or replacing damaged tissue
MX388111B (es) Metodo y composicion para producir agentes regenerativos anti-inflamatorios/anti-catabolicos mejorados a partir de fluido fisiologico autologo.
RU2016130161A (ru) Покрытия для медицинских изделий
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
JP2021500092A5 (enExample)
JP2017507145A5 (enExample)
US20140213524A1 (en) Composition for regeneration of cartilage
US20190022136A1 (en) Micron-sized gold, kit comprising said gold and its use as a non-toxic immune suppressor as well as gold implants
Zhang et al. Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review
MX380536B (es) Composicion y metodo para tratar la enfermedad de chagas.
CN104524633B (zh) 一种基于肌肉的神经支架及其制备方法
US20190343983A1 (en) Scaffold compositions for tissue repair
LT2014117A (lt) Trimatis porėtas celiuliozės karkasas kaulo inžinerijai ir jo gavimo būdas
US20220143268A1 (en) Novel bone putty compositions and methods of use thereof
TWI533861B (zh) 生物可降解之鼻腔塡材製造方法
CA3002679A1 (en) Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease